Indeed, the remarkable similarity of HCDR3 regions within sets of patients strongly supports the notion that B cell receptor (BCR) recognition of particular antigens is a driving force in clonal selection, expansion and evolution in CLL [reviewed in (16, 17)]. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.